74 results found.
      
DePuy Synthes Company Profile
We're redesigning Company Profiles. To get the most current news and articles about DePuy Synthes in the interim,
DJO Company Profile
We're redesigning Company Profiles. To get the most current news and articles about DJO in the interim, please use this ...
DJO Reports 4Q16 and 2016 Revenue
DJO Global posted 2016 revenue of US $1,155.3MM, +3.7% vs. 2015, with 4Q16 revenue of $296.5MM, -3.7% vs. 4Q15...
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
DJO Global 3Q16 Revenue
DJO Global posted 3Q16 revenue of US $287.2MM, +3.2% vs. 3Q15. 
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
DJO Posts 2Q16 Revenue
DJO Global posted 2Q16 revenue of US $292.9MM, +4.6% vs. 2Q15. Growth is as-reported.
Developing New Orthopaedic Business Models: 2020 and Beyond
By Carolyn LaWell  To thrive in the healthcare environment of tomorrow, orthopaedic device companies will need to operate within a greater portion of the supply chain, assisting upstream and downstream customers in finding operational value. This will require companies...
1H16 M&A Recap: Big Players Make Moves
During 1H16, seven of the eight largest orthopaedic device companies confirmed or completed acquisitions or divestitures spanning nearly every orthopaedic market segment. Most notably, Stryker and Zimmer Biomet both announced three orthopaedic-related acquisitions, with Zimmer Biom...
DJO Reports 1Q16 Revenue
DJO Global posted 1Q16 revenue of US $278.9MM, +12.7% vs. 1Q15. (U.S. $203.8MM, +16.2%; ex-U.S. $75.1MM, +4.0%) Growth ...
Orthopaedic Industry Surpassed $46 Billion in 2015

DJO Reports 4Q15/2015 Revenue
DJO Global posted 4Q15 revenue of US $308MM, +9.4% vs. 4Q14, and 2015 revenue of $1.1BB, +6.7% vs. 2014. Growth re...
Company Revenue 2015: DJO
4Q15: $308.0MM, +6.1% 2015 $1,113.7MM, +2.4% (U.S. $817.4MM, +7.2%; ex-U.S. $296.3MM, -8.9%) All growth for 4Q and full-year is as-reported. ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows: Hips $37.8MM, +14.1% Knees $42...
Bundled Payments: AAOS Conversations Center on CJR and Beyond
By Carolyn LaWell The advent of the Centers for Medicare & Medicaid’s Comprehensive Care for Joint Replacement (CJR) program fueled AAOS Annual Meeting conversations regarding the best response by hospitals, surgeons and device companies to bundled payment re...
Proving Medical Necessity: the Need for Evidence in Reimbursement
ORTHOWORLD® Members of all stripes—providers, OEMs and suppliers—say that they’ve been impacted by complexities in the reimbursement system. For example, bundled payments and an increased burden of evidence have changed the way that products are developed and launched. One them...
Joint Active Systems Acquiring Empi Advance ROM Braces
Joint Active Systems signed a non-binding letter of intent to acquire the Empi® Advance®
JNJ Restructuring Expected to Impact DePuy Synthes
By Julie Vetalice  
BARE BONES® - August 11, 2015
CyMedica Orthopedics received approval under the CE Mark for its QB1 Muscle Activation System, designed to treat quadriceps muscle atrophy. (
BARE BONES® - July 30, 2015
Orthopaedic surgery reimbursement model shifts to episode of care. Industry is compelled to adopt declining reimbursements throughout its business models in order to gain the efficiencies—and develop the transf...
BARE BONES® - June 16, 2015
CyMedica Orthopedics closed an extension to its US $11.5MM Series A financing. Funds will support sales and continuted rollout of the QB1™ system for the treatment of quadriceps muscle atrophy
BARE BONES® - April 29, 2015
CyMedica Orthopedics launched CyMedica QB1™, a neuromuscular electrical stimulation system for the treatment of quadriceps muscle atrophy. The device combines a postoperative knee brace, form-fitting
BARE BONES® - March 25, 2015
Following Zimmer's acquisition of Biomet, seven companies will claim 71 percent of the US $45.5BB global orthopaedic market. NuVasive and Aesculap lead the
BARE BONES® - February 20, 2015
DJO Global announced 2014 sales of US $1,229.1MM, +5% from 2013.  (2014 by segment: Bracing/Vascular $504.5MM, +6%; Recovery Sciences $299.1MM, -4%; Surgical Implant $100.1MM, +15%, Internati...
2014 Revenue: DJO
$1,229.1MM, +5% Bracing/Vascular $504.5MM, +6% Recovery Sciences $299.1MM, -4% Surgical Implant $100.1MM, +15% International $325.3MM, +9% Bracing/Vascular includes products serving the diabetes market.
BARE BONES® - February 5, 2015
Ossur announced 2014 Bracing & Support sales of US $295.5MM, +18% vs. 2013. Growth reflects constant currency. (Ossur hf, 2/5/15)
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2017 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group